Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

Gold, Silver Shed Gains Amid Euro Zone Downgrade Talks

By Andrew Burger, InvestorPlace Contributor
Gold trusts and ETFs were headed down Monday morning, but a few miners -- including Agnico-Eagle and Hecla -- were bucking their brethren.

Investors Still Must Pick Generic Drug Companies By Hand

By Barry Cohen, Health Care Writer
The high-risk generic drug sector still is without an ETF, leaving investors to weed out the pharmaceutical winners and losers for themselves.

Investors on Cloud Nine — Monday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
SAP's $3.4 billion bid to buy cloud computing company SuccessFactors puts a jolt into the cloud computing sector.

Growing Medicare Patient Base Could Restore Luster to UnitedHealth Shares

By Barry Cohen, Health Care Writer
UnitedHealth's latest deal is a deft move toward profiting off the growing number of retiring baby boomers.

Gold Softens, Miners Up as Merkel, Sarkozy Meet in Paris

By Andrew Burger, InvestorPlace Contributor
Gold was flat to slightly lower Monday morning, but miners -- especially silver interests like Hecla and Silver Standard -- were enjoying strong gains.

Try PVH on for Size, Leave Warnaco on the Rack

By Peter Cohan, InvestorPlace Writer
The Tommy Hilfiger and Calvin Klein brands helped PVH Corp. exceed earnings expectations and Warnaco is growing, too. But, if you have to leave one on the rack, here's our pick.

Unemployment Report, ECB News Keeps Gold, Silver Buoyant

By Andrew Burger, InvestorPlace Contributor
The Labor Department's unexpectedly strong employment report for November sent stock markets, gold and silver up for a third consecutive morning. The short-term reversal remains…

Wendy’s Facelift Helps Dethrone Burger King

By Jeff Reeves
With McDonald entrenched at No. 1, Wendy’s aimed for second place-- and the strategy appears to be paying off.

The 3 Worst Investments You Can Make

By Lawrence Meyers, InvestorPlace Contributor
These three companies are already plenty far from their highs, but they're still ripe for another stock price plunge.

Clash of the Coffee Stock Titans: Starbucks Vs. Dunkin’ Brands

By Hilary Kramer, Editor, GameChangers
For consumers, Starbucks or Dunkin' is just a choice between frilly frappes and average joe. But for investors, one stock offers more bang for the buck.

3 Yellow Lights After November’s Strong U.S. Auto Sales

By Susan J. Aluise, Aviation, Auto & Transportation Writer
U.S. auto sales hit a two-year high, but the road ahead is hardly trouble-free. Carmakers -- and investors -- have to remain alert to these three yellow lights.

Onyx Pharma May See Suitors Lining Up

By Barry Cohen, Health Care Writer
The company's current and future drugs are likely attractive to larger companies faced with slowing growth.

9 Tech Stocks That Can Sizzle in a Sluggish Economy

By Louis Navellier, Editor, Growth Investor
Customer loyalty, big growth and cost savings make tech stocks like Altera, Salesforce and Apple attractive to both businesses and consumers.

Lemons for Lulu, Barnes & Noble: Thursday’s IP Market Recap

By Kyle Woodley, Senior Investing Editor, Kiplinger
Barnes & Noble (BKS), Lululemon Athletica (LULU) take a licking after disappointing earnings reports Thursday.

Starbucks Is Expanding Against the Grain

By Jeff Reeves
Even though it got burned by aggressive growth before, international expansion is a must for Starbucks, which just announced a big move in the U.K.

Lululemon Athletica: Yet Another Momentum Stock Tailspin

By Jeff Reeves
Lululemon appears to be following the Netflix and Green Mountain script, proving that what goes up quickly can often come down just as fast.

Gold, Silver Cautiously Higher as Attention Shifts Back to Euro Zone

By Andrew Burger, InvestorPlace Contributor
Trusts and mining ETFs were mixed Thursday morning, while numerous gold and silver miners were headed lower.

Yahoo, Don’t Blow It — Again

By Jonathan Berr, InvestorPlace Contributor
Accepting a complete buyout is Yahoo's only sensible move. A repeat of the 2008 Microsoft rejection would be a disaster.

Ranbaxy Closes In on FDA Approval for Generic Lipitor

By Barry Cohen, Health Care Writer
Ranbaxy could sell $650 million worth of the drug in its first 180 days. But Pfizer is battling hard to keep branded Lipitor alive.
Load More Articles